| Style | Citing Format |
|---|---|
| MLA | Willasch AM, et al.. "Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study." Bone Marrow Transplantation, vol. 55, no. 8, 2020, pp. 1540-1551. |
| APA | Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitraroussou V, Yesilipek A, Wachowiak J, Lankester A, Prete A, Hamidieh AA, Ifversen M, Buechner J, Krivan G, Hamladji RM, Diazdeheredia C, Skorobogatova E, Michel G, Locatelli F, Bertaina A, ... Bader P (2020). Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study. Bone Marrow Transplantation, 55(8), 1540-1551. |
| Chicago | Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitraroussou V, Yesilipek A, Wachowiak J, et al.. "Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study." Bone Marrow Transplantation 55, no. 8 (2020): 1540-1551. |
| Harvard | Willasch AM et al. (2020) 'Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study', Bone Marrow Transplantation, 55(8), pp. 1540-1551. |
| Vancouver | Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitraroussou V, Yesilipek A, et al.. Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study. Bone Marrow Transplantation. 2020;55(8):1540-1551. |
| BibTex | @article{ author = {Willasch AM and Peters C and Sedlacek P and Dalle JH and Kitraroussou V and Yesilipek A and Wachowiak J and Lankester A and Prete A and Hamidieh AA and Ifversen M and Buechner J and Krivan G and Hamladji RM and Diazdeheredia C and Skorobogatova E and Michel G and Locatelli F and Bertaina A and Veys P and Dupont S and Or R and Gungor T and Aleinikova O and Sufliarska S and Sundin M and Rascon J and Kaare A and Nemet D and Fagioli F and Klingebiel TE and Styczynski J and Bierings M and Nagy K and Abecasis M and Afanasyev B and Ansari M and Vettenranta K and Alseraihy A and Chybicka A and Robinson S and Bertrand Y and Kupesiz A and Ghavamzadeh A and Campos A and Pichler H and Dalissier A and Labopin M and Corbacioglu S and Balduzzi A and Galimard JE and Bader P}, title = {Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study}, journal = {Bone Marrow Transplantation}, volume = {55}, number = {8}, pages = {1540-1551}, year = {2020} } |
| RIS | TY - JOUR AU - Willasch AM AU - Peters C AU - Sedlacek P AU - Dalle JH AU - Kitraroussou V AU - Yesilipek A AU - Wachowiak J AU - Lankester A AU - Prete A AU - Hamidieh AA AU - Ifversen M AU - Buechner J AU - Krivan G AU - Hamladji RM AU - Diazdeheredia C AU - Skorobogatova E AU - Michel G AU - Locatelli F AU - Bertaina A AU - Veys P AU - Dupont S AU - Or R AU - Gungor T AU - Aleinikova O AU - Sufliarska S AU - Sundin M AU - Rascon J AU - Kaare A AU - Nemet D AU - Fagioli F AU - Klingebiel TE AU - Styczynski J AU - Bierings M AU - Nagy K AU - Abecasis M AU - Afanasyev B AU - Ansari M AU - Vettenranta K AU - Alseraihy A AU - Chybicka A AU - Robinson S AU - Bertrand Y AU - Kupesiz A AU - Ghavamzadeh A AU - Campos A AU - Pichler H AU - Dalissier A AU - Labopin M AU - Corbacioglu S AU - Balduzzi A AU - Galimard JE AU - Bader P TI - Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study JO - Bone Marrow Transplantation VL - 55 IS - 8 SP - 1540 EP - 1551 PY - 2020 ER - |